Our Commitment to Global Health Equity 

While the world has made significant progress in providing improved healthcare, major gaps remain. Exacerbated by the COVID-19 pandemic, bolder, smarter approaches are needed to overcome the drastic inequity in access to care—now more than ever.             

Through a dedicated global public health (GPH) organization that combines world-class research and development, global strategy, human-centered design and external affairs capabilities, and local implementation and impact teams, we put the world’s most underserved at the heart of everything we do—measuring our success in lives improved.              

As a team of innovators, we are committed to pioneering and sustainably delivering meaningful and transformational products in areas where we believe we can make a profound difference: from expanding access to care in HIV and tuberculosis to addressing & preventing future pandemics. Working with global and local partners, we ensure the critical solutions necessary are within reach of those who need them to save lives, cure patients and prevent disease.        

Upholding the rich heritage of Johnson & Johnson, we are taking on the toughest challenges, and, ultimately, we will do our part to close the gap of inequity and pave the way to a healthier future where all people and communities can thrive.

Read more in our Health for Humanity report, which highlights the progress we’ve made against our Health for Humanity 2025 goals and in implementing our environmental, governance and social impact (ESG) strategy to deliver enduring impact and drive better health for all.  

Visit us at  www.jnj.com/gph and follow us on Twitter and Instagram at @JNJGlobalHealth.